On May 6, 2020, BioNTech US Inc. (f/k/a Neon Therapeutics, Inc.) (the Company or Neon), completed its previously announced merger BioNTech SE Endor Lights, Inc., a direct,
wholly owned subsidiary of Parent (Merger Sub"), pursuant to the Agreement and Plan of Merger, dated as of January 15, 2020, by and among Parent, Merger Sub and Neon (the Merger Agreement"). Neon was the surviving corporation of the Merger and, as a result of the Merger, has become a wholly owned subsidiary of Parent (the Surviving Corporation"). In accordance with the Merger, each of Hugh O'Dowd, Robert Bazemore, Cary Pfeffer, Robert Kamen, Eric Lander, Stephen Sherwin, Robert Tepper and Meryl Zausner ceased serving as directors of Neon, and new directors will be appointed to the board of directors of the surviving corporation. In addition, at the Effective Time, following the closing of the Merger, each named executive officer of the Company listed below ceased to hold the positions indicated beside such executive officer's name: Hugh O'Dowd President and Chief Executive Officer; Yasir B. Al-Wakeel Chief Financial Officer. At or following the Effective Time of the Merger, Neon expects to enter into a separation agreement and release with each of Hugh O'Dowd and Yasir B. Al-Wakeel, entitling each executive to severance benefits in accordance with their respective existing employment agreements, dated June 29, 2018 for each of Mr. O'Dowd and Mr. Al-Wakeel.